Correlation Between Eyenovia and PDS Biotechnology
Can any of the company-specific risk be diversified away by investing in both Eyenovia and PDS Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyenovia and PDS Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyenovia and PDS Biotechnology Corp, you can compare the effects of market volatilities on Eyenovia and PDS Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyenovia with a short position of PDS Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyenovia and PDS Biotechnology.
Diversification Opportunities for Eyenovia and PDS Biotechnology
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Eyenovia and PDS is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Eyenovia and PDS Biotechnology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PDS Biotechnology Corp and Eyenovia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyenovia are associated (or correlated) with PDS Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PDS Biotechnology Corp has no effect on the direction of Eyenovia i.e., Eyenovia and PDS Biotechnology go up and down completely randomly.
Pair Corralation between Eyenovia and PDS Biotechnology
Given the investment horizon of 90 days Eyenovia is expected to under-perform the PDS Biotechnology. In addition to that, Eyenovia is 1.41 times more volatile than PDS Biotechnology Corp. It trades about -0.03 of its total potential returns per unit of risk. PDS Biotechnology Corp is currently generating about -0.03 per unit of volatility. If you would invest 886.00 in PDS Biotechnology Corp on September 2, 2024 and sell it today you would lose (667.00) from holding PDS Biotechnology Corp or give up 75.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eyenovia vs. PDS Biotechnology Corp
Performance |
| Timeline |
| Eyenovia |
| PDS Biotechnology Corp |
Eyenovia and PDS Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eyenovia and PDS Biotechnology
The main advantage of trading using opposite Eyenovia and PDS Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyenovia position performs unexpectedly, PDS Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PDS Biotechnology will offset losses from the drop in PDS Biotechnology's long position.| Eyenovia vs. Reviva Pharmaceuticals Holdings | Eyenovia vs. Cidara Therapeutics | Eyenovia vs. Fortress Biotech | Eyenovia vs. Reviva Pharmaceuticals Holdings |
| PDS Biotechnology vs. Mereo BioPharma Group | PDS Biotechnology vs. Terns Pharmaceuticals | PDS Biotechnology vs. Inozyme Pharma | PDS Biotechnology vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |